CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Learn which credit card provides the highest cash back for gas purchases. Fuel your savings today!
27,781 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
SNPD targets 60+ year dividend growers to deliver steady income. This report examines whether its payout remains dura...
If SpaceX joins the exclusive $2 trillion club, it would become the priciest stock among tech giants. This article un...
Adobe Stock sits at a crossroads as the company leans into AI, subscriptions, and enterprise workflows. This guide ex...
Hudbay's 2025 earnings outlook hinges on copper and zinc markets, mine costs, and capital decisions. This guide break...
Two consumer-facing stocks sit at a crossroads: GameStop is tightening its turnaround with a leaner footprint, while ...
As the calendar closes on 2025, Ascendis (ASND) faces the final earnings closeout with questions about cash, pipeline...
A stock split made shares cheaper, but the real driver of Amazon’s rally is its expanding AI and cloud empire. Here’s...
As investors await plug power (plug) 2025 Q4 results, this guide breaks down what the earnings call transcript could ...
Is Meta Platforms a compelling bargain value, or is the stock trapped in a value trap? This guide breaks down the cas...
Plug Power recently beat quarterly estimates, but that isn’t a guarantee the stock is safe to buy. This guide breaks ...
Berkshire Hathaway's July 2026 moves reveal a rotating bet toward cash-generating, earnings-ready names. Delta Air Li...